Restore Bio is developing therapeutics to address multiple disease factors common to complex autoimmune, allergy, and cardiovascular diseases. Our innovative liver-targeted platforms expand potent antigen/tissue-specific regulatory T cells in vivo to manage inflammatory responses and establish a durable catalytic pathway for deep, sustained protein degradation. Our groundbreaking technologies represent a new class of therapeutic solutions designed to address the root causes of disease as well as the acute drivers of pathology.

We are actively building a pipeline of novel therapeutics and seeking partnerships and collaborations to advance multiple products to the clinic.